|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.12 USD | -7.15% |
|
-2.68% | -19.73% |
EPS & Dividend: Legend Biotech Corporation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -2.56 | -2.74 | -2.8 | -2.94 | -0.96 | -0.8358 | 0.4864 | 1.196 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 28.16 | 46.61 | 49.92 | 60.17 | 32.54 | 26.12 | 26.12 | 26.12 |
| Nbr of stocks (in thousands) | 132,638 | 153,946 | 167,403 | 181,789 | 183,451 | 184,690 | - | - |
| Announcement Date | 18/03/21 | 18/03/22 | 30/03/23 | 11/03/24 | 11/03/25 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: Legend Biotech Corporation
| 17/03/2026 | Q4 2025 Earnings Release (Projected) |
| 18/05/2026 | Q1 2026 Earnings Release (Projected) |
| 17/08/2026 | Q2 2026 Earnings Release (Projected) |
| 16/11/2026 | Q3 2026 Earnings Release (Projected) |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | -31.25x | 6.45x | 4.48x | |
| -.--% | -.--% | 50.93x | 8.28x | 12.4x | |
| -.--% | -.--% | -31.88x | 63.71x | 80.89x | |
| 1.75% | 1.66% | 16.2x | 3.82x | 5.68x | |
| -.--% | -.--% | -25.86x | 1.12x | 3.49x | |
| -.--% | -.--% | 17.57x | 3.34x | 4.34x | |
| -.--% | -.--% | 27.79x | 2.57x | 5.44x | |
| -.--% | -.--% | -514.7x | 14.1x | 29.79x | |
| -.--% | -.--% | -14.46x | - | 181.97x | |
| -.--% | -.--% | -190.92x | 23.07x | 47.06x | |
| Average | 0.17% | 0.17% | -69.66x | 14.05x | 37.55x | |
| Weighted average by Cap. | 0.28% | 0.26% | -33.36x | 17.26x | 33.88x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition